nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalidixic Acid—Blister—Hydroxyurea—head and neck cancer	0.0574	0.0585	CcSEcCtD
Nalidixic Acid—Blister—Fluorouracil—head and neck cancer	0.0413	0.0421	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.0314	0.032	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Vinblastine—head and neck cancer	0.0249	0.0254	CcSEcCtD
Nalidixic Acid—Swelling—Fluorouracil—head and neck cancer	0.0245	0.025	CcSEcCtD
Nalidixic Acid—Drowsiness—Hydroxyurea—head and neck cancer	0.0231	0.0236	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.0227	0.0231	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Fluorouracil—head and neck cancer	0.0226	0.0231	CcSEcCtD
Nalidixic Acid—Norfloxacin—CYP1A1—head and neck cancer	0.0197	1	CrCbGaD
Nalidixic Acid—Eosinophilia—Fluorouracil—head and neck cancer	0.0185	0.0189	CcSEcCtD
Nalidixic Acid—Erythema—Hydroxyurea—head and neck cancer	0.0181	0.0184	CcSEcCtD
Nalidixic Acid—Vertigo—Vinblastine—head and neck cancer	0.0178	0.0182	CcSEcCtD
Nalidixic Acid—Leukopenia—Vinblastine—head and neck cancer	0.0177	0.0181	CcSEcCtD
Nalidixic Acid—Swelling—Docetaxel—head and neck cancer	0.0177	0.018	CcSEcCtD
Nalidixic Acid—Convulsion—Vinblastine—head and neck cancer	0.0172	0.0175	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.017	0.0174	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.0163	0.0166	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Docetaxel—head and neck cancer	0.0163	0.0166	CcSEcCtD
Nalidixic Acid—Leukopenia—Hydroxyurea—head and neck cancer	0.0162	0.0165	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Vinblastine—head and neck cancer	0.0158	0.0162	CcSEcCtD
Nalidixic Acid—Convulsion—Hydroxyurea—head and neck cancer	0.0157	0.016	CcSEcCtD
Nalidixic Acid—Paraesthesia—Vinblastine—head and neck cancer	0.0145	0.0148	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.0144	0.0147	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Vinblastine—head and neck cancer	0.0132	0.0135	CcSEcCtD
Nalidixic Acid—Somnolence—Hydroxyurea—head and neck cancer	0.0131	0.0134	CcSEcCtD
Nalidixic Acid—Erythema—Fluorouracil—head and neck cancer	0.013	0.0133	CcSEcCtD
Nalidixic Acid—Abdominal pain—Vinblastine—head and neck cancer	0.0128	0.013	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.0119	0.0122	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Docetaxel—head and neck cancer	0.0118	0.012	CcSEcCtD
Nalidixic Acid—Leukopenia—Fluorouracil—head and neck cancer	0.0116	0.0119	CcSEcCtD
Nalidixic Acid—Asthenia—Vinblastine—head and neck cancer	0.0116	0.0118	CcSEcCtD
Nalidixic Acid—Convulsion—Fluorouracil—head and neck cancer	0.0113	0.0115	CcSEcCtD
Nalidixic Acid—Diarrhoea—Vinblastine—head and neck cancer	0.0111	0.0113	CcSEcCtD
Nalidixic Acid—Dizziness—Vinblastine—head and neck cancer	0.0107	0.0109	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Fluorouracil—head and neck cancer	0.0106	0.0108	CcSEcCtD
Nalidixic Acid—Asthenia—Hydroxyurea—head and neck cancer	0.0106	0.0108	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Fluorouracil—head and neck cancer	0.0104	0.0106	CcSEcCtD
Nalidixic Acid—Visual impairment—Docetaxel—head and neck cancer	0.0104	0.0106	CcSEcCtD
Nalidixic Acid—Vomiting—Vinblastine—head and neck cancer	0.0103	0.0105	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Docetaxel—head and neck cancer	0.0102	0.0104	CcSEcCtD
Nalidixic Acid—Headache—Vinblastine—head and neck cancer	0.0101	0.0103	CcSEcCtD
Nalidixic Acid—Diarrhoea—Hydroxyurea—head and neck cancer	0.0101	0.0103	CcSEcCtD
Nalidixic Acid—Dizziness—Hydroxyurea—head and neck cancer	0.00975	0.00995	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00967	0.00987	CcSEcCtD
Nalidixic Acid—Nausea—Vinblastine—head and neck cancer	0.00961	0.0098	CcSEcCtD
Nalidixic Acid—Paraesthesia—Fluorouracil—head and neck cancer	0.00953	0.00973	CcSEcCtD
Nalidixic Acid—Somnolence—Fluorouracil—head and neck cancer	0.00944	0.00963	CcSEcCtD
Nalidixic Acid—Erythema—Docetaxel—head and neck cancer	0.00939	0.00958	CcSEcCtD
Nalidixic Acid—Vomiting—Hydroxyurea—head and neck cancer	0.00938	0.00957	CcSEcCtD
Nalidixic Acid—Rash—Hydroxyurea—head and neck cancer	0.0093	0.00949	CcSEcCtD
Nalidixic Acid—Dermatitis—Hydroxyurea—head and neck cancer	0.00929	0.00948	CcSEcCtD
Nalidixic Acid—Headache—Hydroxyurea—head and neck cancer	0.00924	0.00943	CcSEcCtD
Nalidixic Acid—Nausea—Hydroxyurea—head and neck cancer	0.00876	0.00894	CcSEcCtD
Nalidixic Acid—Urticaria—Fluorouracil—head and neck cancer	0.00843	0.0086	CcSEcCtD
Nalidixic Acid—Leukopenia—Docetaxel—head and neck cancer	0.0084	0.00857	CcSEcCtD
Nalidixic Acid—Convulsion—Docetaxel—head and neck cancer	0.00814	0.0083	CcSEcCtD
Nalidixic Acid—Arthralgia—Docetaxel—head and neck cancer	0.00799	0.00815	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Docetaxel—head and neck cancer	0.00766	0.00782	CcSEcCtD
Nalidixic Acid—Pruritus—Fluorouracil—head and neck cancer	0.00751	0.00766	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Docetaxel—head and neck cancer	0.0075	0.00765	CcSEcCtD
Nalidixic Acid—Diarrhoea—Fluorouracil—head and neck cancer	0.00726	0.00741	CcSEcCtD
Nalidixic Acid—Dizziness—Fluorouracil—head and neck cancer	0.00702	0.00716	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00698	0.00712	CcSEcCtD
Nalidixic Acid—Paraesthesia—Docetaxel—head and neck cancer	0.00688	0.00702	CcSEcCtD
Nalidixic Acid—Somnolence—Docetaxel—head and neck cancer	0.00681	0.00695	CcSEcCtD
Nalidixic Acid—Vomiting—Fluorouracil—head and neck cancer	0.00675	0.00689	CcSEcCtD
Nalidixic Acid—Rash—Fluorouracil—head and neck cancer	0.00669	0.00683	CcSEcCtD
Nalidixic Acid—Dermatitis—Fluorouracil—head and neck cancer	0.00669	0.00682	CcSEcCtD
Nalidixic Acid—Headache—Fluorouracil—head and neck cancer	0.00665	0.00679	CcSEcCtD
Nalidixic Acid—Nausea—Fluorouracil—head and neck cancer	0.00631	0.00643	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00627	0.00639	CcSEcCtD
Nalidixic Acid—Abdominal pain—Docetaxel—head and neck cancer	0.00606	0.00618	CcSEcCtD
Nalidixic Acid—Asthenia—Docetaxel—head and neck cancer	0.0055	0.00561	CcSEcCtD
Nalidixic Acid—Pruritus—Docetaxel—head and neck cancer	0.00542	0.00553	CcSEcCtD
Nalidixic Acid—Diarrhoea—Docetaxel—head and neck cancer	0.00524	0.00535	CcSEcCtD
Nalidixic Acid—Dizziness—Docetaxel—head and neck cancer	0.00507	0.00517	CcSEcCtD
Nalidixic Acid—Vomiting—Docetaxel—head and neck cancer	0.00487	0.00497	CcSEcCtD
Nalidixic Acid—Rash—Docetaxel—head and neck cancer	0.00483	0.00493	CcSEcCtD
Nalidixic Acid—Dermatitis—Docetaxel—head and neck cancer	0.00483	0.00492	CcSEcCtD
Nalidixic Acid—Headache—Docetaxel—head and neck cancer	0.0048	0.0049	CcSEcCtD
Nalidixic Acid—Nausea—Docetaxel—head and neck cancer	0.00455	0.00464	CcSEcCtD
